United States · FDA National Drug Code directory

Astepro Allergy

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0280-0065_452641af-4731-7fc3-e063-6394a90abceb
Product NDC
0280-0065
Form
SPRAY, METERED
Composition / generic term
Azelastine HCl
Labeler
Bayer HealthCare LLC.
Marketing category
NDA
Marketing start / end (source format)
20220627
Source listing expiry
20261231

Source-listed ingredients

  • AZELASTINE HYDROCHLORIDE — 205.5 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 60 CARTON in 1 BOTTLE (0280-0065-01) / 1 SPRAY, METERED in 1 CARTON · 0280-0065-01
  • 120 CARTON in 1 BOTTLE (0280-0065-02) / 1 SPRAY, METERED in 1 CARTON · 0280-0065-02
  • 120 PACKAGE in 1 BOTTLE (0280-0065-03) / 3 SPRAY, METERED in 1 PACKAGE · 0280-0065-03
  • 200 CARTON in 1 BOTTLE (0280-0065-04) / 1 SPRAY, METERED in 1 CARTON · 0280-0065-04
  • 22 CARTON in 1 BOTTLE (0280-0065-05) / 1 SPRAY, METERED in 1 CARTON · 0280-0065-05
  • 120 CARTON in 1 BOTTLE (0280-0065-09) / 2 SPRAY, METERED in 1 CARTON · 0280-0065-09
  • 22 CARTON in 1 BOTTLE (0280-0065-10) / 1 SPRAY, METERED in 1 CARTON · 0280-0065-10

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →